标题
Real‐world experience of ocrelizumab in multiple sclerosis in a Spanish population
作者
关键词
-
出版物
Annals of Clinical and Translational Neurology
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-12-25
DOI
10.1002/acn3.51282
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Ocrelizumab initiation in patients with MS
- (2020) Erik Ellwardt et al. Neurology-Neuroimmunology & Neuroinflammation
- Real world application of ocrelizumab in multiple sclerosis: Single-center experience of 128 patients
- (2020) Victoria Prockl et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
- (2020) Marina Pollán et al. LANCET
- Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis
- (2020) Céline Louapre et al. JAMA Neurology
- Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab
- (2020) Kulachanya Suwanwongse et al. Multiple Sclerosis and Related Disorders
- Anti-CD20 immunosuppressive disease-modifying therapies and COVID-19
- (2020) Gavin Giovannoni Multiple Sclerosis and Related Disorders
- Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic
- (2020) Mahsa Ghajarzadeh et al. Multiple Sclerosis and Related Disorders
- COVID-19 in persons with multiple sclerosis treated with ocrelizumab – A pharmacovigilance case series
- (2020) Richard Hughes et al. Multiple Sclerosis and Related Disorders
- COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
- (2020) Giovanni Novi et al. Multiple Sclerosis and Related Disorders
- COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies
- (2020) Virginia Meca-Lallana et al. Multiple Sclerosis and Related Disorders
- Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis
- (2019) Benjamin Turner et al. JOURNAL OF NEUROLOGY
- HSV-2-encephalitis in a patient with multiple sclerosis treated with ocrelizumab
- (2019) M. I. R. Dudek et al. JOURNAL OF NEUROLOGY
- Fulminant Hepatitis Associated With Echovirus 25 During Treatment With Ocrelizumab for Multiple Sclerosis
- (2019) Laura Ambra Nicolini et al. JAMA Neurology
- Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
- (2019) Gustavo Luna et al. JAMA Neurology
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Ocrelizumab: A Review in Multiple Sclerosis
- (2018) Yahiya Y. Syed CNS DRUGS
- Reduction in ocrelizumab-induced infusion reactions by a modified premedication protocol
- (2018) William L Conte et al. Multiple Sclerosis and Related Disorders
- Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2017) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Data quality evaluation for observational multiple sclerosis registries
- (2016) Tomas Kalincik et al. Multiple Sclerosis Journal
- Data quality evaluation for observational multiple sclerosis registries
- (2016) Tomas Kalincik et al. Multiple Sclerosis Journal
- Defining reliable disability outcomes in multiple sclerosis
- (2015) Tomas Kalincik et al. BRAIN
- Is it time to target no evident disease activity (NEDA) in multiple sclerosis?
- (2015) Gavin Giovannoni et al. Multiple Sclerosis and Related Disorders
- Defining the clinical course of multiple sclerosis: The 2013 revisions
- (2014) F. D. Lublin et al. NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started